Alicia Rodriguez-Barbero

Dr. Alicia Rodriguez-Barbero

1. Departamento de Fisiología y Farmacología, Universidad de Salamanca, Salamanca, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2008 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
SVSoraya Velasco
Soraya Velasco
PAPatricia Alvarez-Muñoz
Patricia Alvarez-Muñoz
MPMiguel Pericacho
Miguel Pericacho
PDPeter Ten Dijke
Peter Ten Dijke
Carmelo BernabeuCarmelo Bernabeu
Carmelo Bernabeu
ARAlicia Rodriguez-Barbero
Alicia Rodriguez-Barbero
TGFβ regulates cellular processes by binding to type I and type II TGFβ receptors (TβRI and TβRII, respectively). In addition to these signaling receptors, endoglin is an accessory TGFβ receptor that regulates TGFβ signaling. Although there are two different alternatively spliced isoforms of endoglin, L-endoglin (L, long) and S-endoglin (S, short), little is known about the effects of S-endoglin isoform on TGFβ signaling. Here, we have analyzed the TGFβ1 signaling pathways and the effects of L- and S-endoglin in endoglin-deficient L6E9 cells. We found that TGFβ activates two distinct TβRI-Smad signaling pathways: ALK1-Smad1-Id1 and ALK5-Smad2-PAI1, in these cells. Interestingly, L-endoglin enhanced the ALK1-Id1 pathway, while S-endoglin promoted the ALK5-PAI1 route. These effects on signaling are supported by biological effects on TGFβ1-induced collagen I expression and inhibition of cell proliferation. Thus, while L-endoglin decreased TGFβ1-induced collagen I and CTGF expression and increased TGFβ1-induced proliferation, S-endoglin strongly increased TGFβ1-induced collagen I and CTGF expression, and reduced TGFβ1-induced cell proliferation.

1 March 2001 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
ARAlicia Rodriguez-Barbero
Alicia Rodriguez-Barbero
JOJuana Obreo
Juana Obreo
NENélida Eleno
Nélida Eleno
ARAna Rodríguez-Peña
Ana Rodríguez-Peña
ADAnnette Düwel
Annette Düwel
JLJosé M Lopez-Novoa
José M Lopez-Novoa

Verified
Journal Article
Open access
PDF file
LPLucía Pérez-Roque
Lucía Pérez-Roque
ENElena Núñez-Gómez
Elena Núñez-Gómez
ARAlicia Rodriguez-Barbero
Alicia Rodriguez-Barbero
Carmelo BernabeuCarmelo Bernabeu
Carmelo Bernabeu
JLJosé M Lopez-Novoa
José M Lopez-Novoa
MPMiguel Pericacho
Miguel Pericacho
Preeclampsia is a pregnancy-specific disease of high prevalence characterized by the onset of hypertension, among other maternal or fetal signs. Its etiopathogenesis remains elusive, but it is widely accepted that abnormal placentation results in the release of soluble factors that cause the clinical manifestations of the disease. An increased level of soluble endoglin (sEng) in plasma has been proposed to be an early diagnostic and prognostic biomarker of this disease. A pathogenic function of sEng involving hypertension has also been reported in several animal models with high levels of plasma sEng not directly dependent on pregnancy. The aim of this work was to study the functional effect of high plasma levels of sEng in the pathophysiology of preeclampsia in a model of pregnant mice, in which the levels of sEng in the maternal blood during pregnancy replicate the conditions of human preeclampsia. Our results show that wild type pregnant mice carrying human sEng-expressing transgenic fetuses (fWT(hsEng+)) present high plasma levels of sEng with a timing profile similar to that of human preeclampsia. High plasma levels of human sEng (hsEng) are associated with hypertension, proteinuria, fetal growth restriction, and the release of soluble factors to maternal plasma. In addition, fWT(hsEng+) mice also present placental alterations comparable to those caused by the poor remodeling of the spiral arteries characteristic of preeclampsia. In vitro and ex vivo experiments, performed in a human trophoblast cell line and human placental explants, show that sEng interferes with trophoblast invasion and the associated pseudovasculogenesis, a process by which cytotrophoblasts switch from an epithelial to an endothelial phenotype, both events being related to remodeling of the spiral arteries. Our findings provide a novel and useful animal model for future research in preeclampsia and reveal a much more relevant role of sEng in preeclampsia than initially proposed.

1 November 2008 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
FDFernando Dorado
Fernando Dorado
SVSoraya Velasco
Soraya Velasco
AEAzucena Esparís-Ogando
Azucena Esparís-Ogando
MPMiguel Pericacho
Miguel Pericacho
APAtanasio Pandiella
Atanasio Pandiella
ARAlicia Rodriguez-Barbero
Alicia Rodriguez-Barbero
Background. Mesangial activation occurs in many forms of renal disease that progress to renal failure. Mitogen-activated protein kinases (MAPKs) are important mediators involved in the intracellular network of interacting proteins that transduce extracellular stimuli to intracellular responses. The extracellular signal-regulated kinases 5 (Erk5) MAPK pathway has been involved in regulating several cellular responses. Thus, we examined the expression of Erk5 in human renal tissue and the function of Erk5 in cultured human mesangial cells.

17 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MPMiguel Pericacho
Miguel Pericacho
SVSoraya Velasco
Soraya Velasco
MPMarta Prieto
Marta Prieto
Elena LlanoElena Llano
Elena Llano
JLJosé M Lopez-Novoa
José M Lopez-Novoa
ARAlicia Rodriguez-Barbero
Alicia Rodriguez-Barbero
Accurate regulation of dermal fibroblast function plays a crucial role in wound healing. Many fibrotic diseases are characterized by a failure to conclude normal tissue repair and the persistence of fibroblasts inside lesions. In the present study we demonstrate that endoglin haploinsufficiency promotes fibroblast accumulation during wound healing. Moreover, scars from endoglin-heterozygous (Eng+/−) mice show persisting fibroblasts 12 days after wounding, which could lead to a fibrotic scar. Endoglin haploinsufficiency results in increased proliferation and migration of primary cultured murine dermal fibroblasts (MDFs). Moreover, Eng+/− MDF have diminished responses to apoptotic signals compared with control cells. Altogether, these modifications could explain the augmented presence of fibroblasts in Eng+/− mice wounds. We demonstrate that endoglin expression regulates Akt phosphorylation and that PI3K inhibition abolishes the differences in proliferation between endoglin haploinsufficient and control cells. Finally, persistent fibroblasts in Eng+/− mice wound co-localize with a greater degree of Akt phosphorylation. Thus, endoglin haploinsufficiency seems to promote fibroblast accumulation during wound healing through the activation of the PI3K/Akt pathway. These studies open new non-Smad signaling pathway for endoglin regulating fibroblast cell function during wound healing, as new therapeutic opportunities for the treatment of fibrotic wounds.

16 November 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LRLaura Ruiz-Remolina
Laura Ruiz-Remolina
COClaudia Ollauri-Ibáñez
Claudia Ollauri-Ibáñez
LPLucía Pérez-Roque
Lucía Pérez-Roque
ENElena Núñez-Gómez
Elena Núñez-Gómez
FPFernando Pérez-Barriocanal
Fernando Pérez-Barriocanal
ARAlicia Rodriguez-Barbero
Alicia Rodriguez-Barbero
Inflammation is associated with every health condition, and is an important component of many pathologies such as cardiovascular diseases. Circulating levels of soluble endoglin have been shown to be higher in the serum of patients with cardiovascular diseases with a significant inflammatory component. The aim of this study was to evaluate the implication of circulating soluble endoglin in the inflammatory response. For this purpose, a transgenic mouse expressing human soluble endoglin (sEng+) was employed, and three different inflammatory approaches were used to mimic inflammatory conditions in different tissues. This study shows that control sEng+ mice have a normal inflammatory state. The lung and kidney injury induced by the inflammatory agents was reduced in sEng+ mice, especially the intra-alveolar and kidney infiltrates, suggesting a possible reduction in inflammation induced by soluble endoglin. To deepen into this possible effect, the leukocyte number in the bronchoalveolar lavage and air pouch lavage was evaluated and a significant reduction of neutrophil infiltration in LPS-treated lungs and ischemic kidneys from sEng+ with respect to WT mice was observed. Additionally, the mechanisms through which soluble endoglin prevents inflammation were studied. We found that in sEng+ animals the increment of proinflammatory cytokines, TNFα, IL1β and IL6, induced by the inflammatory stimulus was reduced. Soluble endoglin also prevents the augmented adhesion molecules, ICAM, VCAM and E-selectin induced by the inflammatory stimulus. In addition, vascular permeability increased by inflammatory agents was also reduced by soluble endoglin. These results suggest that soluble endoglin modulates inflammatory-related diseases and open new perspectives leading to the development of novel and targeted approaches for the prevention and treatment of cardiovascular diseases.